Articles

GRP78-directed immunotherapy in relapsed or refractory multiple myeloma - results from a phase 1 trial with the monoclonal immunoglobulin M antibody PAT-SM6

Department of Internal Medicine II, University Hospital Würzburg, Germany
Department of Internal Medicine II, University Hospital Würzburg, Germany
Patrys GmbH, Würzburg, Germany
Patrys Ltd., Melbourne, Australia
Department of Internal Medicine II, University Hospital Würzburg, Germany
Department of Internal Medicine II, University Hospital Würzburg, Germany
Patrys GmbH, Würzburg, Germany
Institute of Pathology, University of Würzburg, Germany, and Comprehensive Cancer Center Mainfranken, Germany
Department of Internal Medicine II, University Hospital Würzburg, Germany
Department of Internal Medicine II, University Hospital Würzburg, Germany
Institute of Pathology, University of Würzburg, Germany, and Comprehensive Cancer Center Mainfranken, Germany
Vol. 100 No. 3 (2015): March, 2015 https://doi.org/10.3324/haematol.2014.117945